4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-21-003996
Chief Operations Officer sold 7,000 shares at $18.84 ($131,880)
- Chief Operations Officer acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Newell Joe Chief Operations Officer | 2021-01-15 | Option exercise | +3,500 | $12.15 | $42,525 | 116,555 | D |
| Newell Joe Chief Operations Officer | 2021-01-15 | Sale | −7,000 | $18.84 | $131,880 | 109,555 | D |
| Derivatives | |||||||
| Newell Joe Chief Operations Officer | 2021-01-15 | Option exercise · Employee Stock Option (Right to Buy) | −3,146 | 46,041 | D | ||
| Newell Joe Chief Operations Officer | 2021-01-15 | Option exercise · Employee Stock Option (Right to Buy) | −354 | 13,459 | D | ||
| Open-market sales · 7,000 sh · avg $18.84 · $131,880 | |||||||
Loading xslF345X03/doc4.xml…